{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:09Z","timestamp":1707524229545},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,7]]},"DOI":"10.7759\/cureus.13188","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T08:41:56Z","timestamp":1612773716000},"source":"Crossref","is-referenced-by-count":4,"title":["Clinical Presentation and Successful Management of an Infant With Down Syndrome and COVID-19 in Riyadh, Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Ibrahim","family":"Alsahabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Alobaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman S","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noof","family":"Almohsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah H","family":"Alhamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020920153","article-title":"Care of patients with pulmonary hypertension during the COVID-19 pandemic","volume":"10","author":"Ryan JJ","year":"2020","unstructured":"Ryan JJ, Melnderes-Groves L, Zamanian RT, et al.. Care of patients with pulmonary hypertension during the COVID-19 pandemic. Pulm Circ. 2020,  10:1-7. 10.1177\/2045894020920153","journal-title":"Pulm Circ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020922799","article-title":"Could pulmonary arterial hypertension (PAH) patients be at a lower risk from severe COVID-19?","volume":"10","author":"Horn EM","year":"2020","unstructured":"Horn EM, Chakinala M, Oudiz R, Joseloff E, Rosenzweig EB. Could pulmonary arterial hypertension (PAH) patients be at a lower risk from severe COVID-19?. Pulm Circ. 2020, 10:1-2. 10.1177\/2045894020922799","journal-title":"Pulm Circ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0606-1","article-title":"High positivity of anti-CCP antibodies in patients with Down syndrome","volume":"26","author":"Nisihara RM","year":"2007","unstructured":"Nisihara RM, Skare TL, Silva MB, et al.. High positivity of anti-CCP antibodies in patients with Down syndrome. Clin Rheumatol. 2007, 26:2031-35. 10.1007\/s10067-007-0606-1","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0098-2016","article-title":"What people with Down syndrome can teach us about cardiopulmonary disease","volume":"26","author":"Colvin KL","year":"2017","unstructured":"Colvin KL, Yeager ME. What people with Down syndrome can teach us about cardiopulmonary disease. Eur Respir Rev. 2017, 26:143. 10.1183\/16000617.0098-2016","journal-title":"Eur Respir Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304611","article-title":"An overview of respiratory problems in children with Down's syndrome","volume":"98","author":"Watts R","year":"2013","unstructured":"Watts R, Vyas H. An overview of respiratory problems in children with Down's syndrome. Arch Dis Child. 2013, 98:812-7. 10.1136\/archdischild-2013-304611","journal-title":"Arch Dis Child"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong Y","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics. 2020, 145:20200702. 10.1542\/peds.2020-0702","journal-title":"Pediatrics"},{"key":"ref9","article-title":"Coronavirus disease 2019 in children: United States, February 12-April 2, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team. Coronavirus disease 2019 in children: United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020, 69:422-6.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.05.007","article-title":"Severe COVID-19 in children and young adults in the Washington, DC metropolitan region","volume":"223","author":"DeBiasi RL","year":"2020","unstructured":"DeBiasi RL, Song X, Delaney M, et al.. Severe COVID-19 in children and young adults in the Washington, DC metropolitan region. J Pediatr. 2020, 223:199-203. 10.1016\/j.jpeds.2020.05.007","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease","volume":"141","author":"Clerkin KJ","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, et al.. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020, 141:1648-55. 10.1161\/CIRCULATIONAHA.120.046941","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix168","article-title":"Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with down syndrome","volume":"215","author":"Schoch J","year":"2017","unstructured":"Schoch J, Rohrer TR, Kaestner M, et al.. Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with down syndrome. J Infect Dis. 2017, 215:1619-28. 10.1093\/infdis\/jix168","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.11.058","article-title":"Children with down syndrome are high-risk for severe respiratory syncytial virus disease","volume":"166","author":"Stagliano DR","year":"2015","unstructured":"Stagliano DR, Nylund CM, Eide MB, Eberly MD. Children with down syndrome are high-risk for severe respiratory syncytial virus disease. J Pediatr. 2015, 166:703-9. 10.1016\/j.jpeds.2014.11.058","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Che M, Yuan J, Yu Y, Cao C, Qin XY, Cheng Y. Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis. Oncotarget. 2017, 8:84489-96. 10.18632\/oncotarget.21060","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti P","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, et al.. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020, 34:1. 10.23812\/CONTI-E","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093330","article-title":"Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity","volume":"21","author":"Diamanti AP","year":"2020","unstructured":"Diamanti AP, Rosado MM, Pioli C, Sesti G, Lagana\u0300 B. Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity. Int J Mol Sci. 2020, 21:3330. 10.3390\/ijms21093330","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar R","year":"2017","unstructured":"Channappanavar R, Perlman, S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017, 39:529-39. 10.1007\/s00281-017-0629-x","journal-title":"Semin Immunopathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.2010.00914.x","article-title":"Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome","volume":"37","author":"Cetiner S","year":"2010","unstructured":"Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet. 2010, 37:233-7. 10.1111\/j.1744-313X.2010.00914.x","journal-title":"Int J Immunogenet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram G","year":"2011","unstructured":"Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011, 164:9-16. 10.1111\/j.1365-2249.2011.04335.x","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50278-clinical-presentation-and-successful-management-of-an-infant-with-down-syndrome-and-covid-19-in-riyadh-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:41Z","timestamp":1707507221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50278-clinical-presentation-and-successful-management-of-an-infant-with-down-syndrome-and-covid-19-in-riyadh-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.13188","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,7]]}}}